Federated Hermes, Inc. Blueprint Medicines Corp Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 153,301 shares of BPMC stock, worth $14.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

153,301

Previous 62,354 145.86%

Holding current value

$14.5 Million

Previous $6.72 Million 110.92%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $7.65 Million - $11 Million	90,947 Added 145.86%	153,301 $14.2 Million
Q2 2024 Aug 08, 2024	BUY	$85.18 - $108.78 $1.16 Million - $1.48 Million	13,579 Added 27.84%	62,354 $6.72 Million
Q1 2024 May 14, 2024	BUY	$73.17 - $99.79 $1.81 Million - $2.47 Million	24,732 Added 102.87%	48,775 $4.63 Million
Q4 2023 Jan 31, 2024	BUY	$43.96 - $92.84 $1.06 Million - $2.23 Million	24,043 New	24,043 $2.22 Million
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $20,990 - $42,711	-388 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $2,450 - $3,015	-26 Reduced 6.28%	388 $42,000
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $3.55 Million - $4.8 Million	-43,843 Reduced 99.06%	414 $43,000
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $2.56 Million - $3.13 Million	-30,950 Reduced 41.15%	44,257 $3.89 Million
Q1 2021 May 13, 2021	SELL	$90.71 - $108.28 $3.74 Million - $4.47 Million	-41,267 Reduced 35.43%	75,207 $7.31 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $9.9 Million - $13.4 Million	107,534 Added 1202.84%	116,474 $13.1 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $594,063 - $828,738	8,940 New	8,940 $829,000
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $400 - $495	-6 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $10.4 Million - $14.5 Million	-142,748 Reduced 100.0%	6 $1,000
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $10.5 Million - $14 Million	142,754 New	142,754 $13.5 Million
Q2 2018 Aug 10, 2018	SELL	$60.96 - $101.18 $4.57 Million - $7.58 Million	-74,933 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$73.28 - $102.95 $5.49 Million - $7.71 Million	74,933 New	74,933 $6.87 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Blueprint Medicines Corp Transaction History